国际眼科纵览
國際眼科縱覽
국제안과종람
OREIGN MEDICAL SCIENCES
2012年
4期
266-270
,共5页
青光眼滤过手术%瘢痕%细胞因子
青光眼濾過手術%瘢痕%細胞因子
청광안려과수술%반흔%세포인자
glaucoma filtration surgery%scar%cytokine
手术后瘢痕化是导致青光眼滤过手术失败的主要原因.多种细胞因子,如转化生长因子β(TGF-β)、血管内皮生长因子(VEGF)、结缔组织生长因子(CTGF)、白细胞介素(IL-1)和干扰素(INF)等参与青光眼滤过手术瘢痕化过程的调控.目前已研制出多种针对这些细胞因子的治疗性干预措施,在预防青光眼手术滤过通道瘢痕化方面具有很好的应用前景.本文对参与调控青光眼滤过手术瘢痕化的细胞因子以及针对性治疗措施进行综述.
手術後瘢痕化是導緻青光眼濾過手術失敗的主要原因.多種細胞因子,如轉化生長因子β(TGF-β)、血管內皮生長因子(VEGF)、結締組織生長因子(CTGF)、白細胞介素(IL-1)和榦擾素(INF)等參與青光眼濾過手術瘢痕化過程的調控.目前已研製齣多種針對這些細胞因子的治療性榦預措施,在預防青光眼手術濾過通道瘢痕化方麵具有很好的應用前景.本文對參與調控青光眼濾過手術瘢痕化的細胞因子以及針對性治療措施進行綜述.
수술후반흔화시도치청광안려과수술실패적주요원인.다충세포인자,여전화생장인자β(TGF-β)、혈관내피생장인자(VEGF)、결체조직생장인자(CTGF)、백세포개소(IL-1)화간우소(INF)등삼여청광안려과수술반흔화과정적조공.목전이연제출다충침대저사세포인자적치료성간예조시,재예방청광안수술려과통도반흔화방면구유흔호적응용전경.본문대삼여조공청광안려과수술반흔화적세포인자이급침대성치료조시진행종술.
Following all types of glaucoma filtration surgery,scarring still poses the major threat to long-term success.Many cytokines,such as transforming growth factor-β (TGF-β),vascular endothelial growth factor (VEGF),connective tissue growth factor (CTGF),interleukin (IL) and interferon (INF),are associated with the scarring progress after filtration surgery.Recently,many promising new agents were used therapeutically by binding to these molecular targets among scar regulation after glaucoma surgery.In this review,we discuss our current understanding of cytokines in the wound healing process after glaucoma surgery and promising new treatment modalities.